Iodopol, 37-7400 MBq, hard capsules

Okres ważności: 

21 days from the manufacturing date

Warunki przechowywania: 


Store below 25°C.


Store in the original package to avoid radiation exposure from the product.


Storage of radiopharmaceuticals should be in accordance with national regulations on radioactive materials.


Postać farmaceutyczna: 


Hard capsule.


Medium orange hard gelatin capsule, approximately 18 mm long, containing white powder.


Skład jakościowy i ilościowy substancji czynnych: 


One capsule contains sodium iodide (131I) 37 - 7400 MBq at time of calibration.


Wykaz substancji pomocniczych: 


Capsule contents:


Sodium carbonate


Sodium hydrogen carbonate


Sodium hydroxide


Disodium phosphate dihydrate


Sodium thiosulfate




Gelatin capsule shell composition:


Quinoline yellow (E 104)


Erythrosine (E 127)


Titanium dioxide (E 171)


Rodzaj i zawartość opakowania: 


The polypropylene vial placed in a shielding lead container, closed with a lead stopper which contains polypropylene insert with iodine absorber. The package contains a single capsule. Each package is accompanied by a separate polypropylene applicator for capsule administration.

Wskazania do stosowania: 


Radioiodide thyroid therapy is indicated in adults and children for:


- hyperthyroidism: treatment of Graves’ disease, toxic multinodular goitre or autonomous nodules. 


- treatment of large euthyroid (nontoxic) goitre.


- treatment of papillary and follicular thyroid carcinoma, including metastatic disease. 


Sodium Iodide (131I) therapy is often combined with surgical intervention and with antithyroid medicinal products.




Nasza siedziba